Patrick Clarence Machado

Affiliations

  • at Alumis Inc. (ALMS), 2024-07-01
  • at Adverum Biotechnologies Inc. (ADVM), 2024-06-20
  • Director at Acelyrin Inc. (SLRN), 2024-06-11
  • Director at Arcus Biosciences Inc. (RCUS), 2024-06-07
  • at Xenon Pharmaceuticals Inc. (XENE), 2024-06-05
  • Director at Turnstone Biologics Corp. (TSBX), 2023-07-21
  • Director at Chimerix Inc (CMRX), 2023-06-12
  • Director at Turning Point Therapeutics Inc. (TPTX), 2022-08-17
  • Director at Roivant Sciences Ltd. (ROIV), 2021-10-01
  • Director at Principia Biopharma Inc. (PRNB), 2020-09-28
  • Other at Arbutus Biopharma Corp (ABUS), 2019-07-16
  • Other at Myovant Sciences Ltd. (MYOV), 2019-07-16
  • Other at Axovant Gene Therapies Ltd. (AXON), 2019-07-16
  • Other at Urovant Sciences Ltd. (UROV), 2019-07-16
  • Director at Scynexis Inc (SCYX), 2019-01-04
  • Director at Endocyte Inc (ECYT), 2018-12-21
  • Director at Inotek Pharmaceuticals Corp (ITEK), 2017-06-21
  • Director at Medivation Inc. (MDVN), 2016-09-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ADVM $9.92 10,000 Director 88,182 2021-03-24 Filing
ADVM $11.52 10,000 Director 78,182 2021-01-15 Filing
UROV $8.17 4,957 Large Shareholder 22,860,013 2019-06-19 Filing
UROV $8.21 6,706 Large Shareholder 22,855,056 2019-06-18 Filing
UROV $8.53 6,541 Large Shareholder 22,848,350 2019-06-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MDVN $39.19 6,950 Director 66,156 2016-01-19 Filing
MDVN $38.62 7,942 Director 73,106 2016-01-19 Filing
MDVN $37.50 23,087 Director 81,048 2016-01-19 Filing
MDVN $36.62 37,021 Director 104,135 2016-01-19 Filing
MDVN $43.92 17,680 Director 66,156 2015-09-25 Filing